MINAXI COUTURE LIMITED
Company number 14685992 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
MINAXI COUTURE LIMITED - Analysis Report
Company Number: 14685992
Analysis Date: 2025-07-29 14:55 UTC
Financial Health Assessment Report for MINAXI COUTURE LIMITED
1. Financial Health Score: Grade D
Explanation:
The company shows clear symptoms of financial distress, with persistent negative net current assets and shareholders’ funds indicating an ongoing capital deficiency. While the business is still active and operational, its liquidity position is strained, and reliance on director’s advances suggests it is not yet self-sustaining financially.
2. Key Vital Signs
| Metric | Latest Year (2025) | Interpretation |
|---|---|---|
| Fixed Assets | £637 | Minimal long-term asset base, typical for micro-entity. |
| Current Assets | £0 | No liquid or short-term assets available to meet obligations. |
| Current Liabilities | £33,292 | Significant short-term debts due within a year. |
| Net Current Assets | -£33,292 | Indicates a liquidity shortfall; unable to cover immediate debts. |
| Total Assets Less Current Liabilities | -£32,655 | Negative net asset position, showing insolvency risk. |
| Shareholders Funds | -£32,655 | Equity is negative, meaning liabilities exceed assets. |
| Director’s Advances | -£33,510 | Director has financially supported the company; reliance on insider funding. |
| Average Number of Employees | 1 | Micro business scale, limited operational capacity. |
3. Diagnosis: Underlying Financial Condition
MINAXI COUTURE LIMITED presents with symptoms of financial distress, primarily due to its negative working capital position and erosion of shareholders’ equity. The company’s current liabilities substantially exceed its current assets, creating a liquidity gap that the company cannot cover from its own resources.
This liquidity deficit is currently being managed through director’s advances, which indicates the company is dependent on external support to meet short-term obligations. Such reliance is akin to a patient borrowing medication to alleviate symptoms without addressing the root cause of illness.
The company’s fixed asset base is minimal, reflecting a lean operational model but also limiting its ability to leverage assets for financing. The negative net asset position signals the company is technically insolvent on a balance sheet basis, which is a critical warning sign.
Given the business is newly incorporated (2023), the negative equity may reflect startup losses and initial investment shortfalls. However, if this trend continues without generating healthy cash flow or securing external funding, the risk of insolvency will increase.
4. Recommendations: Path to Financial Recovery
To improve the company’s financial wellness, the following steps are advised:
Improve Liquidity (Healthy Cash Flow):
Focus on generating positive cash flow from operations. This may involve cost control, improving sales, or negotiating better payment terms with suppliers and customers.Reduce Current Liabilities:
Explore restructuring short-term debts or converting some liabilities to longer-term financing to ease immediate pressure.Capital Injection:
Consider additional equity funding from the director or external investors to restore positive net assets and strengthen the balance sheet.Regular Financial Monitoring:
Implement monthly cash flow forecasting and financial review to detect early symptoms of distress and act promptly.Explore Revenue Growth Opportunities:
Given the retail SIC code, diversify product offerings or enhance online presence to increase sales volume.Professional Advisory:
Engage with a financial advisor or turnaround specialist to develop a sustainable business plan and financial structure.
Medical Analogy Summary:
MINAXI COUTURE LIMITED’s balance sheet reveals a company with a weak pulse in liquidity and capital—akin to a patient with low blood pressure and depleted reserves. The director’s advances act like emergency IV fluids, temporarily stabilising but not curing the underlying condition. Without intervention to restore financial vitality, the company risks further deterioration.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.